Table of Contents

2019-2024 Global Donepezil Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Donepezil Consumption 2014-2024
  • 2.1.2 Donepezil Consumption CAGR by Region
• 2.2 Donepezil Segment by Type
  • 2.2.1 5mg
  • 2.2.2 10mg
  • 2.2.3 23mg
• 2.3 Donepezil Consumption by Type
  • 2.3.1 Global Donepezil Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Donepezil Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Donepezil Sale Price by Type (2014-2019)
• 2.4 Donepezil Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Drugstore
• 2.5 Donepezil Consumption by Application
  • 2.5.1 Global Donepezil Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Donepezil Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Donepezil Sale Price by Application (2014-2019)

3 Global Donepezil by Players

• 3.1 Global Donepezil Sales Market Share by Players
  • 3.1.1 Global Donepezil Sales by Players (2017-2019)
  • 3.1.2 Global Donepezil Sales Market Share by Players (2017-2019)
• 3.2 Global Donepezil Revenue Market Share by Players
  • 3.2.1 Global Donepezil Revenue by Players (2017-2019)
  • 3.2.2 Global Donepezil Revenue Market Share by Players (2017-2019)
• 3.3 Global Donepezil Sale Price by Players
• 3.4 Global Donepezil Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Donepezil Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Donepezil Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Donepezil by Regions

• 4.1 Donepezil by Regions
  • 4.1.1 Global Donepezil Consumption by Regions
  • 4.1.2 Global Donepezil Value by Regions
• 4.2 Americas Donepezil Consumption Growth
• 4.3 APAC Donepezil Consumption Growth
• 4.4 Europe Donepezil Consumption Growth
• 4.5 Middle East & Africa Donepezil Consumption Growth

5 Americas

• 5.1 Americas Donepezil Consumption by Countries
  • 5.1.1 Americas Donepezil Consumption by Countries (2014-2019)
  • 5.1.2 Americas Donepezil Value by Countries (2014-2019)
• 5.2 Americas Donepezil Consumption by Type
• 5.3 Americas Donepezil Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Donepezil Consumption by Countries
  • 6.1.1 APAC Donepezil Consumption by Countries (2014-2019)
  • 6.1.2 APAC Donepezil Value by Countries (2014-2019)
• 6.2 APAC Donepezil Consumption by Type
• 6.3 APAC Donepezil Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Donepezil by Countries
  • 7.1.1 Europe Donepezil Consumption by Countries (2014-2019)
  • 7.1.2 Europe Donepezil Value by Countries (2014-2019)
• 7.2 Europe Donepezil Consumption by Type
• 7.3 Europe Donepezil Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Donepezil by Countries
  • 8.1.1 Middle East & Africa Donepezil Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Donepezil Value by Countries (2014-2019)
• 8.2 Middle East & Africa Donepezil Consumption by Type
• 8.3 Middle East & Africa Donepezil Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Donepezil Distributors
• 10.3 Donepezil Customer

11 Global Donepezil Market Forecast

• 11.1 Global Donepezil Consumption Forecast (2019-2024)
• 11.2 Global Donepezil Forecast by Regions
  • 11.2.1 Global Donepezil Forecast by Regions (2019-2024)
  • 11.2.2 Global Donepezil Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Donepezil Forecast by Type
• 11.8 Global Donepezil Forecast by Application

12 Key Players Analysis

• 12.1 Eisai
  • 12.1.1 Company Details
  • 12.1.2 Donepezil Product Offered
  • 12.1.3 Eisai Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Eisai News
• 12.2 Pfizer
  • 12.2.1 Company Details
  • 12.2.2 Donepezil Product Offered
  • 12.2.3 Pfizer Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Pfizer News
• 12.3 Teva
  • 12.3.1 Company Details
  • 12.3.2 Donepezil Product Offered
  • 12.3.3 Teva Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Teva News
• 12.4 Sandoz
  • 12.4.1 Company Details
  • 12.4.2 Donepezil Product Offered
  • 12.4.3 Sandoz Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Sandoz News
• 12.5 Apotex
  • 12.5.1 Company Details
  • 12.5.2 Donepezil Product Offered
  • 12.5.3 Apotex Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Apotex News
• 12.6 Dr Reddy's Laboratories
  • 12.6.1 Company Details
  • 12.6.2 Donepezil Product Offered
  • 12.6.3 Dr Reddy's Laboratories Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Dr Reddy's Laboratories News
• 12.7 Sun Pharmaceutical
  • 12.7.1 Company Details
  • 12.7.2 Donepezil Product Offered
  • 12.7.3 Sun Pharmaceutical Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Sun Pharmaceutical News
• 12.8 Hansoh Pharma
  • 12.8.1 Company Details
  • 12.8.2 Donepezil Product Offered
  • 12.8.3 Hansoh Pharma Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Hansoh Pharma News
• 12.9 Cipla
  • 12.9.1 Company Details
  • 12.9.2 Donepezil Product Offered
  • 12.9.3 Cipla Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Cipla News
• 12.10 ARK PHA.LTD
  • 12.10.1 Company Details
  • 12.10.2 Donepezil Product Offered
  • 12.10.3 ARK PHA.LTD Donepezil Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 ARK PHA.LTD News
• 12.11 Jishengtang Pharma
• 12.12 Luoxin

13 Research Findings and Conclusion

Donepezil is a medication used in the palliative treatment of Alzheimer's disease. Donepezil is used to improve cognition and behavior of people with Alzheimer's, but does not slow the progression of or cure the disease.

Common side effects include loss of appetite, gastrointestinal upset, diarrhea, difficulty sleeping, vomiting, or muscle cramping.
The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.
North America is the largest consumption region of Donepezil, with a sales market share nearly 37% in 2017. Europe is the second largest consumption region of Donepezil, enjoying Sales market share nearly 29% in 2017.
Donepezil was developed by Eisai and Pfizer and is sold as a generic by multiple suppliers. Donepezil acts as a centrally acting reversible acetylcholinesterase inhibitor.

According to this study, over the next five years the Donepezil market will register a -1.6% CAGR in terms of revenue, the global market size will reach US$ 830 million by 2024, from US$ 920 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Donepezil business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Donepezil market by product type, application, key manufacturers and key regions and countries.

This study considers the Donepezil value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
5mg
10mg
23mg
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Drugstore

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical 
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Donepezil consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Donepezil market by identifying its various subsegments.
Focuses on the key global Donepezil manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Donepezil with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Donepezil submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.